More than consent for ethical open-label placebo research

Area of Science:

• Medical Ethics
• Clinical Research
• Psychosomatic Medicine

Background:

• Open-label placebos (OLPs) are increasingly studied for conditions like chronic pain and IBS.
• OLPs avoid deception by informing participants they receive a placebo.
• This transparency is seen as overcoming ethical hurdles of traditional placebo use.

Purpose of the Study:

• To explore ethical considerations of open-label placebo research beyond deception.
• To argue for a broader ethical framework for OLP studies.
• To examine historical context influencing OLP appropriateness.

Main Methods:

• Literature review and ethical analysis.
• Examination of informed consent principles in research ethics.
• Historical analysis of placebo use in clinical settings.

Main Results:

• While OLPs eliminate deception, other ethical issues remain.
• Informed consent is a necessary but insufficient ethical safeguard.
• Historical patterns of placebo prescription raise structural ethical questions.

Conclusions:

• Ethical OLP research requires moving beyond a narrow focus on deception.
• Consideration of historical context and patient selection is crucial.
• A comprehensive ethical framework is needed for OLP clinical investigation and use.